Respiratory Clinical Trials in India offer massive patient pools, 40-70% lower costs, and faster timelines for US sponsors. Explore strategic advantages for asthma, COPD and pulmonary studies. As a US sponsor navigating today’s competitive drug development landscape, you face constant…